Retatrutide is a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By activating these receptors, https://heathhgxl456235.digiblogbox.com/60752654/retatrutide-a-promising-new-treatment-for-obesity